Furthermore, our data showed the comparable effects of global (pharmacologic) and genetic inhibition of PRMT3 on tumor growth and therapeutic outcomes, suggesting that PRMT3 inhibitors may mediate its anti-tumor effects through inhibition of PRMT3 expression in cancer cells. This evidence concerns the gene PRMT3 and cancer.